Zeng YL - Search Results

1

[A novel method for hepatitis C virus genotyping using RT-PCR reverse dot blot hybridization technique].

Wei JF, Zhang TS, Huang HH, Zeng YL, Zhang F, Wang JJ, Zhou B, Wu YS, Liu SW, Hou JL, Guo YB, Zhou YP. Wei JF, et al. Among authors: zeng yl. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Oct;30(10):2270-2, 2276. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20965822 Chinese.

2

[Preparation of human anti-HBs from volunteers with hepatitis B vaccine boost vaccination by modified B-cell immortalization technique].

Lou HB, Zhou YP, Zhou FY, Zhang MX, Wei JF, Zeng YL, Wang JJ, Wang YJ, Wu AH, Hou JL. Lou HB, et al. Among authors: zeng yl. Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):949-52. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20501364 Chinese.

3

[Relationship between single nucleotide polymorphisms in IL28B gene and response to interferon treatment in chronic hepatitis B patients].

Chen CM, Zhou FY, Zhou YP, Zeng YL, Li W, Hou JL. Chen CM, et al. Among authors: zeng yl. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Dec;31(12):2012-5. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 22200702 Chinese.

4

[Construction and sequence analysis of recombinant HCV-1b replicon by replacing NS5A region].

Li J, Zhou B, Zhou Y, Zeng Y, Li W, Wang J, Zhang J, Zhang H, Liu S. Li J, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jan;32(1):46-9. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22366003 Chinese.

5

Predicting sustained viral response to hepatitis C using a rapid and simple IL28B rs8099917 genotyping assay.

Li W, Zeng Y, Wang J, Zhou B, Zhang J, Zhang H, Li J, Wu Y, Hamoudi R, Zhou Y. Li W, et al. Antiviral Res. 2012 Apr;94(1):54-6. doi: 10.1016/j.antiviral.2012.02.007. Epub 2012 Feb 22. Antiviral Res. 2012. PMID: 22387386

6

Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C.

Zeng Y, Li W, Li J, Wang J, Zhou B, Zhang J, Liu S, Wu Y, Hou J, Zhou Y. Zeng Y, et al. Arch Virol. 2012 Jun;157(6):1113-21. doi: 10.1007/s00705-012-1283-1. Epub 2012 Mar 18. Arch Virol. 2012. PMID: 22426896 Clinical Trial.

7

[Interferon treatment of chronic hepatitis C-induced ischemic bowel disease: two case reports and a literature review].

Wei J, Kang Y, Zeng Y, Shang J. Wei J, et al. Zhonghua Gan Zang Bing Za Zhi. 2014 Dec;22(12):955-7. Zhonghua Gan Zang Bing Za Zhi. 2014. PMID: 25799603 Review. Chinese. No abstract available.

8

Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.

Ma L, Wei J, Zeng Y, Liu J, Xiao E, Kang Y, Kang Y. Ma L, et al. Drug Deliv. 2022 Dec;29(1):440-453. doi: 10.1080/10717544.2022.2030428. Drug Deliv. 2022. PMID: 35099348 Free PMC article.

9

[Genomic diversity of the genotype 1b hepatitis C virus open reading frame is correlated with outcomes of combined pegylated-interferon/ribavirin therapy in patients with chronic hepatitis C from Henan Province].

Zeng Y, Kang Y, Shang J. Zeng Y, et al. Zhonghua Gan Zang Bing Za Zhi. 2014 Jun;22(6):401-6. doi: 10.3760/cma.j.issn.1007-3418.2014.06.001. Zhonghua Gan Zang Bing Za Zhi. 2014. PMID: 25203700 Chinese.

10

Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.

Ma L, Zeng Y, Wei J, Yang D, Ding G, Liu J, Shang J, Kang Y, Ji X. Ma L, et al. Biomed Pharmacother. 2018 Nov;107:1728-1735. doi: 10.1016/j.biopha.2018.08.156. Epub 2018 Sep 10. Biomed Pharmacother. 2018. PMID: 30257391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters